Seller is PVC Europe Group, Luxembourg-based investment subsidiary of Investindustrial. (London). Benvic’s medical activities in Italy are planned to remain with the current owner.

Frankfurt, Germany-based strategic investor ICIG said it will integrate the Benvic compounding activities with more than 600 employees and annual sales of just under €500 million into a new group division called Compounds. The business will continue to operate under the Benvic branding and market approach.

Since its buyout, Benvic has been transformed into a “global leader in thermoplastic solutions,” thanks to a program of 10 add-on acquisitions across Europe and the US, Investindustrial said.“ This successful strategy,” the private equity investor said, allowed the plastics company to “significantly grow both sales and EBITDA and evolve from a niche compounder into a well-diversified platform poised for continued growth.”

Benvic has also consolidated its position as a “first mover and leader” on ESG matters, Industrialinvest added, by making contributions to the United Nation’s Sustainable Development Goals (SDGs). The compounder also completed an ESG-linked refinancing, as “one of the first of its kind in the European market” and also embraced the circular economy by developing sustainable and renewable materials.

The French compounder founded in 1963 as a subsidiary of Solvay, develops, produces and markets customized thermoplastic solutions based on PVC, engineering compounds and biopolymer that are used in a wide range of rigid and flexible end-applications. It has production facilities in France, Italy, Spain, Poland, the UK and the US.

Author: Dede Williams, Freelance Journalist